{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:05:35Z","timestamp":1769105135208,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T00:00:00Z","timestamp":1533168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12888-018-1822-8","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T09:21:02Z","timestamp":1533201662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Kathrin","family":"Nickel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Gl\u00e4ser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Stock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fgene.2013.00076","volume":"4","author":"P Imbrici","year":"2013","unstructured":"Imbrici P, Camerino DC, Tricarico D. Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Front Genet. 2013;4:76.","journal-title":"Front Genet"},{"key":"1822_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.gene.2013.09.073","volume":"532","author":"ME Celle","year":"2013","unstructured":"Celle ME, Cuoco C, Porta S, Gimelli G, Tassano E. Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures. Gene. 2013;532:294\u20136.","journal-title":"Gene"},{"issue":"Pt 11","key":"1822_CR3","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1113\/jphysiol.2010.188482","volume":"588","author":"MH Meisler","year":"2010","unstructured":"Meisler MH, O\u2019Brien JE, Sharkey LM. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol. 2010;588(Pt 11):1841\u20138.","journal-title":"J Physiol"},{"key":"1822_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/hmg\/8.5.805","volume":"8","author":"A Philippe","year":"1999","unstructured":"Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, R\u00e5stam M, Sponheim E, et al. Genome-wide scan for autism susceptibility genes. Paris autism research international Sibpair study. Hum Mol Genet. 1999;8:805\u201312.","journal-title":"Hum Mol Genet"},{"key":"1822_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.mp.4001241","volume":"8","author":"LA Weiss","year":"2003","unstructured":"Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry. 2003;8:186\u201394.","journal-title":"Mol Psychiatry"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yebeh.2011.11.022","volume":"23","author":"AC Bender","year":"2012","unstructured":"Bender AC, Morse RP, Scott RC, Holmes GL, Lenck-Santini P-P. SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome. Epilepsy Behav EB. 2012;23:177\u201386.","journal-title":"Epilepsy Behav EB"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/ajmg.a.38282","volume":"173","author":"SV Le","year":"2017","unstructured":"Le SV, Le PHT, Le TKV, Kieu Huynh TT, Hang Do TT. A mutation in GABRB3 associated with Dravet syndrome. Am J Med Genet A. 2017;173:2126\u201331.","journal-title":"Am J Med Genet A"},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature10945","volume":"485","author":"SJ Sanders","year":"2012","unstructured":"Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485:237\u201341.","journal-title":"Nature"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20029","volume":"55","author":"SF Berkovic","year":"2004","unstructured":"Berkovic SF, Heron SE, Giordano L, Marini C, Guerrini R, Kaplan RE, et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol. 2004;55:550\u20137.","journal-title":"Ann Neurol"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1523\/JNEUROSCI.3089-03.2004","volume":"24","author":"K Kamiya","year":"2004","unstructured":"Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci. 2004;24:2690\u20138.","journal-title":"J Neurosci"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","volume":"75","author":"Y Liao","year":"2010","unstructured":"Liao Y, Anttonen A-K, Liukkonen E, Gaily E, Maljevic S, Schubert S, et al. SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology. 2010;75:1454\u20138.","journal-title":"Neurology"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1212\/WNL.0b013e3181b9cebc","volume":"73","author":"I Ogiwara","year":"2009","unstructured":"Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, et al. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology. 2009;73:1046\u201353.","journal-title":"Neurology"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1399-0004.2010.01526.x","volume":"80","author":"M Bartnik","year":"2011","unstructured":"Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P. Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Clin Genet. 2011;80:191\u20135.","journal-title":"Clin Genet"},{"key":"1822_CR14","doi-asserted-by":"crossref","unstructured":"Davidsson J, Collin A, Olsson ME, Lundgren J, Soller M. Deletion of the SCN gene cluster on 2q24.4 is associated with severe epilepsy: an array-based genotype-phenotype correlation and a comprehensive review of previously published cases. Epilepsy Res. 2008;81:69\u201379.","DOI":"10.1016\/j.eplepsyres.2008.04.018"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2007.12.064","volume":"433","author":"KD Holland","year":"2008","unstructured":"Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, et al. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neurosci Lett. 2008;433:65\u201370.","journal-title":"Neurosci Lett"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejmg.2010.03.006","volume":"53","author":"C-P Chen","year":"2010","unstructured":"Chen C-P, Lin S-P, Chern S-R, Chen Y-J, Tsai F-J, Wu P-C, et al. Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2-->q24.3 in a girl with autistic features and developmental delay. Eur J Med Genet. 2010;53:217\u201320.","journal-title":"Eur J Med Genet."},{"key":"1822_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.164","volume":"7","author":"LQ Uddin","year":"2017","unstructured":"Uddin LQ, Dajani DR, Voorhies W, Bednarz H, Kana RK. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit\/hyperactivity disorder. Transl Psychiatry. 2017;7:e1218.","journal-title":"Transl Psychiatry"},{"key":"1822_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.909","volume":"43","author":"GM Cooper","year":"2011","unstructured":"Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43:838\u201346.","journal-title":"Nat Genet"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tins.2004.06.003","volume":"27","author":"K Gurney","year":"2004","unstructured":"Gurney K, Prescott TJ, Wickens JR, Redgrave P. Computational models of the basal ganglia: from robots to membranes. Trends Neurosci. 2004;27:453\u20139.","journal-title":"Trends Neurosci"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"13307","DOI":"10.1073\/pnas.0502624102","volume":"102","author":"PSA Kalanithi","year":"2005","unstructured":"Kalanithi PSA, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A. 2005;102:13307\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1822_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/cne.22206","volume":"518","author":"Y Kataoka","year":"2010","unstructured":"Kataoka Y, Kalanithi PSA, Grantz H, Schwartz ML, Saper C, Leckman JF, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol. 2010;518:277\u201391.","journal-title":"J Comp Neurol"},{"key":"1822_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainres.2011.02.083","volume":"1389","author":"W Wang","year":"2011","unstructured":"Wang W, Takashima S, Segawa Y, Itoh M, Shi X, Hwang S-K, et al. The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe. Brain Res. 2011;1389:61\u201370.","journal-title":"Brain Res"},{"key":"1822_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00424-003-1117-9","volume":"447","author":"B Mackenzie","year":"2004","unstructured":"Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (system N\/a) transporters of the SLC38 gene family. Pflugers Arch. 2004;447:784\u201395.","journal-title":"Pflugers Arch"},{"key":"1822_CR24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/leu.2017.72","volume":"31","author":"SH Han","year":"2017","unstructured":"Han SH, Kim S-H, Kim H-J, Lee Y, Choi S-Y, Park G, et al. Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia. Leukemia. 2017;31:1532\u20139.","journal-title":"Leukemia"},{"issue":"Pt 2","key":"1822_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20050216","volume":"388","author":"LJ Holt","year":"2005","unstructured":"Holt LJ, Siddle K. Grb10 and Grb14: enigmatic regulators of insulin action--and more? Biochem J. 2005;388(Pt 2):393\u2013406.","journal-title":"Biochem J"},{"key":"1822_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.braindev.2014.10.008","volume":"37","author":"VCN Wong","year":"2015","unstructured":"Wong VCN, Fung CW, Kwong AKY. SCN2A mutation in a Chinese boy with infantile spasm - response to modified Atkins diet. Brain and Development. 2015;37:729\u201332.","journal-title":"Brain and Development"},{"key":"1822_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yebeh.2013.09.032","volume":"29","author":"EH Kossoff","year":"2013","unstructured":"Kossoff EH, Cervenka MC, Henry BJ, Haney CA, Turner Z. A decade of the modified Atkins diet (2003\u20132013): results, insights, and future directions. Epilepsy Behav EB. 2013;29:437\u201342.","journal-title":"Epilepsy Behav EB."},{"key":"1822_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tins.2012.11.005","volume":"36","author":"A Lutas","year":"2013","unstructured":"Lutas A, Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013;36:32\u201340.","journal-title":"Trends Neurosci"},{"issue":"Suppl 2","key":"1822_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1469-8749.2011.03967.x","volume":"53","author":"C Chiron","year":"2011","unstructured":"Chiron C. Current therapeutic procedures in Dravet syndrome. Dev Med Child Neurol. 2011;53(Suppl 2):16\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"1822_CR30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","volume":"356","author":"C Chiron","year":"2000","unstructured":"Chiron C, Marchand MC, Tran A, Rey E, d\u2019Athis P, Vincent J, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet Lond Engl. 2000;356:1638\u201342.","journal-title":"Lancet Lond Engl"},{"key":"1822_CR31","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of Cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376:2011\u201320.","journal-title":"N Engl J Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-018-1822-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-018-1822-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T23:06:55Z","timestamp":1564700815000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-018-1822-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s12888-018-1822-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]},"assertion":[{"value":"28 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Written informed consent was obtained from the parents of the patient for the case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents of the patient for publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Kathrin Nickel: no conflict of interest. Ludger Tebartz van Elst has received advisory boards, lectures, or travel grants within the last 3\u00a0years: Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. Katharina Domschke: no conflict of interest. Birgitta Gl\u00e4ser: no conflict of interest. Friedrich Stock: no conflict of interest. Dominique Endres: no conflict of interest. Simon Maier: no conflict of interest. Andreas Riedel: no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"248"}}